Chenyu Peng Selected Research

Fulvestrant (Faslodex)

12/2020

Radioiodinated estradiol dimer for estrogen receptor targeted breast cancer imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chenyu Peng Research Topics

Disease

7	Neoplasms (Cancer) 12/2020 - 11/2017
5	Breast Neoplasms (Breast Cancer) 12/2020 - 01/2018
1	Ischemic Stroke 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Myocardial Infarction 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018

Drug/Important Bio-Agent (IBA)

2	Estrogen ReceptorsIBA 12/2020 - 01/2018
2	Estradiol (Delestrogen)FDA LinkGeneric 12/2020 - 01/2018
2	TriazolesIBA 12/2020 - 11/2017
2	Progesterone Receptors (Progesterone Receptor)IBA 05/2019 - 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2022
1	diestradiolIBA 12/2020
1	Fulvestrant (Faslodex)FDA Link 12/2020
1	Molecular Probes (Molecular Probe)IBA 01/2020
1	Testosterone (Sustanon)FDA Link 05/2019
1	EthisteroneIBA 05/2019
1	PalladiumIBA 10/2018
1	Radioisotopes (Radionuclides)IBA 10/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	16-fluoroestradiolIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	2- methoxy- N- (3- (4- ((3- methyl- 4- ((6- methyl- 3- pyridinyl)oxy)phenyl)amino)- 6- quinazolinyl)- 2- propenyl)acetamideIBA 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2017
1	Ethylene Glycol (Monoethylene Glycol)IBA 11/2017

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2018
2	Precision Medicine 01/2022 - 10/2018
1	Photothermal Therapy 10/2018
1	Radiotherapy 10/2018